Enzon Pharmaceuticals Price Prediction

ENZNDelisted Stock  USD 0.20  0.01  5.26%   
As of today, The relative strength index (RSI) of Enzon Pharmaceuticals' share price is at 53 suggesting that the otc stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Enzon Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

53

 
Oversold
 
Overbought
Enzon Pharmaceuticals stock price prediction is an act of determining the future value of Enzon Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Enzon Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Enzon Pharmaceuticals and does not consider all of the tangible or intangible factors available from Enzon Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Enzon Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Enzon Pharmaceuticals based on different types of headlines from major news networks to social media. Using Enzon Pharmaceuticals hype-based prediction, you can estimate the value of Enzon Pharmaceuticals from the perspective of Enzon Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Enzon Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Enzon Pharmaceuticals to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Enzon because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Enzon Pharmaceuticals after-hype prediction price

    
  USD 0.2  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Intrinsic
Valuation
LowRealHigh
0.160.160.22
Details
Naive
Forecast
LowNextHigh
0.200.200.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.180.190.20
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Enzon Pharmaceuticals. Your research has to be compared to or analyzed against Enzon Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Enzon Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Enzon Pharmaceuticals.

Enzon Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Enzon Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enzon Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Enzon Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Enzon Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Enzon Pharmaceuticals' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enzon Pharmaceuticals' historical news coverage. Enzon Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.20 and 0.20, respectively. We have considered Enzon Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.20
0.20
After-hype Price
0.20
Upside
Enzon Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Enzon Pharmaceuticals is based on 3 months time horizon.

Enzon Pharmaceuticals OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Enzon Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enzon Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enzon Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
8 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.20
0.20
0.00 
0.00  
Notes

Enzon Pharmaceuticals Hype Timeline

Enzon Pharmaceuticals is currently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Enzon is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Enzon Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.20. About 49.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.04. Enzon Pharmaceuticals last dividend was issued on the 30th of September 2019. The entity had 1:1 split on the 29th of September 2017. Given the investment horizon of 90 days the next forecasted press release will be in a few days.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.

Enzon Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Enzon Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Enzon Pharmaceuticals' future price movements. Getting to know how Enzon Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enzon Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PMVPPmv Pharmaceuticals(0.01)3 per month 0.00 (0.05) 4.35 (4.73) 13.98 
NAMSNewAmsterdam Pharma 0.64 9 per month 3.42  0.07  6.54 (5.11) 45.12 
TPSTTempest Therapeutics 0.02 5 per month 0.00 (0.03) 6.38 (8.42) 24.26 
IOBTIO Biotech(0.15)8 per month 0.00 (0.07) 6.10 (8.25) 26.99 
MLPHMolecular Pharmacology 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CUBTCurative Biotechnology 0.0009 3 per month 11.18  0.09  25.27 (24.17) 85.65 
CDAKQCodiak BioSciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
KAKineta Inc 0.15 2 per month 0.00 (0.03) 10.45 (10.00) 41.46 
OVITOncoVista Innovative Therapies 0.00 0 per month 0.00  0.12  0.00  0.00  100.00 
NTIINeurobiological Technologies 0.00 3 per month 0.00  0.00  0.00  0.00  0.00 
GNCAQGenocea Biosciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
POLXFPolydex Pharmaceuticals 0.00 0 per month 0.00  0.13  6.42 (3.02) 213.88 
CYCCCyclacel Pharmaceuticals(0.02)10 per month 0.00 (0.09) 15.79 (15.66) 48.10 
LVCLFLiving Cell Technologies 0.00 0 per month 0.00 (0.05) 0.00  0.00  91.48 
MCETMulticell Techs 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MRESInstitute of Biomedical 0.00 0 per month 5.94  0.21  44.07 (14.71) 102.95 
HESGHealth Sciences Gr 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MYMXMymetics Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ELYMELYM Old 0.25 4 per month 0.00 (0.23) 6.00 (9.35) 22.16 
MOLNMolecular Partners AG 0.02 5 per month 4.53  0.06  8.52 (7.22) 52.92 
OPTOpthea 0.18 9 per month 0.00 (0.07) 7.43 (7.49) 17.06 
PRTCPureTech Health PLC(0.58)4 per month 0.00 (0.06) 5.53 (5.04) 16.42 
ACRVAcrivon Therapeutics, Common(1.04)3 per month 0.00 (0.05) 8.45 (9.66) 26.67 

Enzon Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Enzon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enzon using various technical indicators. When you analyze Enzon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Enzon Pharmaceuticals Predictive Indicators

The successful prediction of Enzon Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enzon Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enzon Pharmaceuticals based on analysis of Enzon Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enzon Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enzon Pharmaceuticals's related companies.

Story Coverage note for Enzon Pharmaceuticals

The number of cover stories for Enzon Pharmaceuticals depends on current market conditions and Enzon Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enzon Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enzon Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Enzon Pharmaceuticals Short Properties

Enzon Pharmaceuticals' future price predictability will typically decrease when Enzon Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enzon Pharmaceuticals often depends not only on the future outlook of the potential Enzon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enzon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding74.2 M
Forward Annual Dividend Rate0.12
Shares Float30.2 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Enzon OTC Stock

If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity